O10 Characteristics of patients who discontinued baricitinib treatment within 12 months and reasons for discontinuation: real-world data
May Nwe Lwin(Southampton General Hospital), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Christopher Holroyd(Southampton General Hospital)
Cited by 29
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668
Vitamin D supplementation in pregnancy: a systematic review
|Health Technology Assessment|2014|353